OPEN-SOURCE SCRIPT
Stx Monthly Trades Profit
Updated
Monthly profit displays profits in a grid and allows you to know the gain related to the investment during each month.
The profit could be computed in terms of gain/trade_cost or as percentage of equity update.
Settings:
- Profit: Monthly profit percentage or percentage of equity
- Table position
This strategy is intended only as a container for the code and for testing the script of the profit table.
Setting of strategy allows to select the test case for this snippet (percentage grid).
Money management: not relevant as strategy is a test case.
This script stand out as take in account the gain of each trade in relation to the capital invested in each trade. For example consider the following scenario:
Capital of 1000$ and we invest a fixed amount of 1000$ (I know is too risky but is a good example), we gain 10% every month.
After 10 months our capital is of 2000$ and our strategy is perfect as we have the same performance every month.
Instead, evaluating the percentage of equity we have 10% the first month, 9.9% the second (1200$/1100$ - 1) and 5.26% the tenth month. So seems that strategy degrade with times but this is not true.
For this reason, to evaluate my strategy I prefer to see the montly return of investment.
WARNING: The strategy provided with this script is only a test case and allows to see the behavior with different "trades" management, for these reason commision are set to zero.
At the moment only the provided test cases are handled:
test 1 - single entry and single exit;
test 2 - single entry and multiple exits;
test 3 - single entry and switch position;
The profit could be computed in terms of gain/trade_cost or as percentage of equity update.
Settings:
- Profit: Monthly profit percentage or percentage of equity
- Table position
This strategy is intended only as a container for the code and for testing the script of the profit table.
Setting of strategy allows to select the test case for this snippet (percentage grid).
Money management: not relevant as strategy is a test case.
This script stand out as take in account the gain of each trade in relation to the capital invested in each trade. For example consider the following scenario:
Capital of 1000$ and we invest a fixed amount of 1000$ (I know is too risky but is a good example), we gain 10% every month.
After 10 months our capital is of 2000$ and our strategy is perfect as we have the same performance every month.
Instead, evaluating the percentage of equity we have 10% the first month, 9.9% the second (1200$/1100$ - 1) and 5.26% the tenth month. So seems that strategy degrade with times but this is not true.
For this reason, to evaluate my strategy I prefer to see the montly return of investment.
WARNING: The strategy provided with this script is only a test case and allows to see the behavior with different "trades" management, for these reason commision are set to zero.
At the moment only the provided test cases are handled:
test 1 - single entry and single exit;
test 2 - single entry and multiple exits;
test 3 - single entry and switch position;
Release Notes
Update documentationRelease Notes
fix position reversal conditionRelease Notes
add leverage setting for monthly_profit, in this way the script consider the profit_for_each_trade related to the trade investment as invested_capital * leverage.Release Notes
add yearly summaryRelease Notes
Highlight the cell with min and max value.The first cell, starting from past with min, max is highlighted. Consider that values on the table are rounded therefore you can see highlighted value not at the first occourrence. For example 2.001% and 2.002% are shown both as 2% but the second will be higlighted.
Open-source script
In true TradingView spirit, the author of this script has published it open-source, so traders can understand and verify it. Cheers to the author! You may use it for free, but reuse of this code in publication is governed by House rules. You can favorite it to use it on a chart.
Want to use this script on a chart?
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.